Omnicare Pharmacy Pays $15.3M Penalty For Lax Control Over Controlled Drug ‘Kits’

(May 14, 2020, 1:56 PM EDT) -- “Closed door” institutional pharmacy Omnicare Inc. has agreed to pay a $15.3 million civil penalty to resolve allegations that it violated federal drug law by allowing opioids and other controlled drugs...
To view the full article, register now.